
In an interview with Pharmacy Times, Ali A. Habib, MD, clinical professor of neurology at the University of California, Irvine, discusses what the hospitalization findings mean for patients and why they should be viewed as supportive evidence
David Lassen, chief clinical officer at Prime Therapeutics, discusses important developments in specialty pharmacy.
David Lassen, chief clinical officer at Prime Therapeutics, discusses important developments in specialty pharmacy.
